Direkt zum Inhalt
Merck

Discovery of indole-modified aptamers for highly specific recognition of protein glycoforms.

Nature communications (2021-12-09)
Alex M Yoshikawa, Alexandra Rangel, Trevor Feagin, Elizabeth M Chun, Leighton Wan, Anping Li, Leonhard Moeckl, Diana Wu, Michael Eisenstein, Sharon Pitteri, H Tom Soh
ZUSAMMENFASSUNG

Glycosylation is one of the most abundant forms of post-translational modification, and can have a profound impact on a wide range of biological processes and diseases. Unfortunately, efforts to characterize the biological function of such modifications have been greatly hampered by the lack of affinity reagents that can differentiate protein glycoforms with robust affinity and specificity. In this work, we use a fluorescence-activated cell sorting (FACS)-based approach to generate and screen aptamers with indole-modified bases, which are capable of recognizing and differentiating between specific protein glycoforms. Using this approach, we were able to select base-modified aptamers that exhibit strong selectivity for specific glycoforms of two different proteins. These aptamers can discriminate between molecules that differ only in their glycan modifications, and can also be used to label glycoproteins on the surface of cultured cells. We believe our strategy should offer a generally-applicable approach for developing useful reagents for glycobiology research.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ribonuklease A aus Rinderpankreas, for molecular biology, ≥70 Kunitz units/mg protein, lyophilized
Sigma-Aldrich
Fetuin from fetal bovine serum, lyophilized powder
Sigma-Aldrich
Asialofetuin aus Kälberserum fötal, Type I (Sigma designation)
Sigma-Aldrich
Ribonuklease B aus Rinderpankreas, Proteomics Grade